Processa Pharmaceuticals, Inc. (PCSA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$1.92M2017: -$1.80M2018: -$4.52M2019: -$3.94M2020: -$15.14M2021: -$12.13M2022: -$27.53M2023: -$11.46M2024: -$12.05M2025: -$13.99M-$13.99M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$13.99M-16.1%
2024-$12.05M-5.2%
2023-$11.46M+58.4%
2022-$27.53M-126.9%
2021-$12.13M+19.8%
2020-$15.14M-284.6%
2019-$3.94M+13.0%
2018-$4.52M-151.0%
2017-$1.80M+6.2%
2016-$1.92M